查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1933297

全球女性健康醫療器材市場：市場規模、佔有率、成長率、產業分析、依類型、應用和地區劃分的考量因素以及未來預測（2026-2034）

Women's Health Devices Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 110 Pages | 商品交期: 請詢問到貨日

價格

女性健康醫療器材市場成長驅動因素

預計2025年全球女性健康醫療器材市場規模將達到603.9億美元，從2026年的658.9億美元增長至2034年的1415.7億美元，在預測期內（2026-2034年）的複合年增長率（CAGR）為10.03%。北美地區將在2025年佔45.70%的市場佔有率，這主要得益於強勁的醫療保健支出、女性疾病的高發生率以及對技術先進的醫療器材日益增長的需求。

女性健康意識的提高、可支配收入的增加以及乳腺癌、卵巢癌等女性特有癌症和子宮肌瘤等疾病的發病率上升，是推動市場成長的關鍵因素。此外，年輕一代女性對先進健康監測和診斷設備的日益普及也促進了整體市場的擴張。

市場概覽

女性健康領域的最新趨勢促使各公司加大研發投入，推出涵蓋診斷和監測設備以及治療設備的新產品。例如，2021年12月，羅氏公司推出了用於晚期或轉移性乳癌的cobas PIK3CA突變檢測，提高了治療的精準度，並促進了設備的普及。

由於就診量減少和供應鏈中斷，新冠疫情暫時阻礙了市場成長。 例如，Cooper Surgical公司報告稱，其不孕症治療業務在2020年的收入下降了11.2%。然而，在2021年，該市場復甦，銷售額增長了39.2%，這得益於遠距醫療和遠距患者護理解決方案的日益普及。

市場驅動因素

女性健康問題意識的提升

醫療保健基礎設施的改善以及美國食品藥物管理局（FDA）女性健康計畫等機構所進行的宣傳活動，顯著提高了早期檢測和預防保健醫療器材的使用率。這些努力產生了顯著影響，尤其是在年輕女性族群中，從而增加了對診斷、治療和監測設備的需求。

女性疾病的成長趨勢

由於子宮頸癌、乳癌和子宮肌瘤等女性特有的癌症和慢性疾病發生率不斷上升，對專用醫療器械的需求也在增長。根據世界衛生組織2022年的報告，子宮頸癌是女性第四大常見癌症，2020年報告的新病例達60.4萬例。這些趨勢正在推動研發和產品上市，進一步促進市場成長。

限制因子

新興地區意識水平低和醫療保健普及率低限制了市場成長。在印度和撒哈拉以南非洲等國家，文化禁忌、診斷意識低下以及先進設備的匱乏導致女性健康技術未被充分利用，從而抑制了整體市場擴張。

目錄

第一章：引言

第二章：摘要整理

第三章：市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第四章：關鍵考慮因素

  • 各國及地區主要疾病盛行率（2025 年）
  • 概述：女性健康醫療器材市場的新興公司與創新
  • 關鍵產業趨勢：併購、合作等
  • 新冠疫情對女性健康醫療器材市場的影響

章節5 全球女性健康醫療器材市場分析：洞察與預測 (2021-2034)

  • 市場分析、洞察與預測：依應用領域劃分
    • 一般健康與保健
    • 癌症及其他慢性疾病
    • 生殖健康
    • 孕期及哺乳期護理
    • 骨盆腔及子宮保健
    • 其他
  • 市場分析、洞察與預測：依最終用戶劃分
    • 醫院及診所
    • 家庭醫療保健
    • 其他
  • 市場分析、洞察與預測：依地區劃分
    • 北美
    • 歐洲
    • 亞太地區
    • 世界其他地區 (ROW)

第六章 北美女性健康醫療器材市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 美國
    • 加拿大

第七章：歐洲女性健康醫療器材市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 其他歐洲國家

第八章：亞太地區女性健康醫療器材市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 其他國家/地區亞太地區

第九章：世界其他地區（ROW）女性健康醫療器材市場分析：洞察與預測（2021-2034）

第十章：競爭分析

  • 全球市佔率分析（2025）
  • 公司簡介
  • Coloplast A/S
  • Hologic, Inc.
  • Boston Scientific Corporation
  • ALLERGAN(AbbVie, Inc.)
  • BD(Becton, Dickinson and Company)
  • F. Hoffmann-La Roche Ltd
  • CooperSurgical Inc.(The Cooper Companies, Inc.)
  • Caldera Medical
  • Reckitt Benckiser Group PLC
Product Code: FBI105732

Growth Factors of women's health devices Market

The global women's health devices market was valued at USD 60.39 billion in 2025 and is projected to grow from USD 65.89 billion in 2026 to USD 141.57 billion by 2034, registering a CAGR of 10.03% during the forecast period (2026-2034). North America dominated the market in 2025 with a 45.70% share, driven by strong healthcare expenditure, a high prevalence of female diseases, and growing demand for technologically advanced medical devices.

Rising awareness of female health issues, increased disposable incomes, and the growing prevalence of female cancers, such as breast and ovarian cancers, and other conditions like uterine fibroids are major factors driving market growth. Additionally, younger generations of women are increasingly adopting advanced health monitoring and diagnostic devices, boosting overall market expansion.

MARKET OVERVIEW

Recent developments in the women's health space have motivated companies to invest heavily in R&D and new product launches, ranging from diagnostic and monitoring devices to therapeutic equipment. For example, in December 2021, F. Hoffmann-La Roche Ltd launched the cobas PIK3CA Mutation Test for advanced or metastatic breast cancer, enhancing treatment precision and driving device adoption.

The COVID-19 pandemic temporarily hindered market growth due to limited hospital visits and disrupted supply chains. CooperSurgical Inc., for instance, reported an 11.2% revenue decline in 2020 in its fertility segment. However, by 2021, the market rebounded with 39.2% sales growth, aided by the increasing adoption of telemedicine and remote patient care solutions.

MARKET DRIVERS

Increasing Awareness of Women's Health Issues

Enhanced healthcare infrastructure, coupled with awareness campaigns by organizations like the U.S. FDA's Health of Women Program, has significantly increased women's adoption of health devices for early detection and preventive care. These initiatives have been particularly influential among younger women, leading to greater demand for diagnostic, therapeutic, and monitoring devices.

Rising Prevalence of Female Diseases

The growing prevalence of female cancers and chronic conditions such as cervical cancer, breast cancer, and uterine fibroids has escalated demand for specialized medical devices. According to WHO 2022, cervical cancer is the 4th most common cancer among women, with 604,000 new cases reported in 2020. Such trends are driving R&D initiatives and product launches, further propelling market growth.

RESTRAINING FACTORS

Limited awareness and low healthcare penetration in emerging regions restrict market growth. In countries like India and sub-Saharan Africa, cultural taboos, low diagnostic awareness, and limited access to advanced devices result in underutilization of women's health technologies, restraining overall market expansion.

SEGMENTATION

By Application

The cancers & other chronic diseases segment accounted for 34.74% of the market in 2026, due to high demand for effective diagnostic and therapeutic devices. The pregnancy & nursing care segment and reproductive health segment follow, driven by adoption of pregnancy diagnostics, breast pumps, and contraceptive devices. Pelvic and uterine healthcare devices, including urinary incontinence solutions, are also witnessing strong growth.

By End-User

Hospitals and clinics dominated the market in 2026 with a 59.42% share, due to patient influx for diagnostic and therapeutic treatments. Home healthcare is growing fastest, as patients increasingly prefer convenient at-home monitoring solutions. The "others" segment, which includes specialized clinics and telemedicine services, is growing steadily.

REGIONAL INSIGHTS

North America led the market with USD 27.60 billion in 2025, supported by strong government initiatives, technological adoption, and healthcare investments. Europe followed, with Germany and the U.K. expected to reach USD 4.48 billion and USD 2.85 billion by 2026, respectively, driven by high prevalence of female cancers and robust healthcare infrastructure.

Asia Pacific is projected to register the strongest CAGR due to increasing awareness, improved healthcare infrastructure, and approvals for advanced devices. Japan, China, and India are expected to reach USD 3.87 billion, USD 4.68 billion, and USD 2.2 billion by 2026, respectively. Emerging regions, including Latin America and the Middle East & Africa, are experiencing moderate growth due to improving healthcare access and increasing awareness.

KEY INDUSTRY PLAYERS

Prominent players include F. Hoffmann-La Roche Ltd., Boston Scientific Corporation, CooperSurgical Inc., Hologic Inc., Coloplast A/S, and ALLERGAN (AbbVie, Inc.). These companies are strengthening their portfolios through R&D, acquisitions, and strategic partnerships. For instance, CooperSurgical acquired Cook Medical's reproductive health portfolio for USD 875 million in 2022, expanding offerings in fertility, obstetrics, and gynecology devices.

CONCLUSION

The global women's health devices market is poised for robust growth from USD 60.39 billion in 2025 to USD 141.57 billion by 2034, driven by increasing prevalence of female diseases, awareness campaigns, technological advancements, and home healthcare adoption. Despite challenges in emerging markets, strategic investments, R&D innovations, and government initiatives are expected to sustain market expansion, making the sector highly attractive for global players and new entrants alike.

Segmentation By Application, End-user, and Region

By Application * General Health & Wellness

  • Cancers & Other Chronic Diseases
  • Reproductive Health
  • Pregnancy & Nursing Care
  • Pelvic & Uterine Healthcare
  • Others

By End-user * Hospitals & Clinics

  • Home Healthcare
  • Others

By Region * North America (By Application, By End-user, and By Country)

    • U.S.
    • Canada
  • Europe (By Application, By End-user, and By Country/Sub-Region)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific (By Application, By End-user, and By Country/Sub-Region)
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia Pacific
  • Rest of the World (By Application and By End-user)

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Key Disease Indications, By Key Countries/ Regions, 2025
  • 4.2. Overview: Start-ups and Innovations in the Women's Health Devices Market
  • 4.3. Key Industry Developments - Mergers, Acquisitions, and Partnerships
  • 4.4. Impact of COVID-19 on the Women's Health Devices Market

5. Global Women's Health Devices Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Application
    • 5.1.1. General Health & Wellness
    • 5.1.2. Cancers & Other Chronic Diseases
    • 5.1.3. Reproductive Health
    • 5.1.4. Pregnancy & Nursing Care
    • 5.1.5. Pelvic & Uterine Healthcare
    • 5.1.6. Others
  • 5.2. Market Analysis, Insights and Forecast - By End User
    • 5.2.1. Hospitals & Clinics
    • 5.2.2. Home Healthcare
    • 5.2.3. Others
  • 5.3. Market Analysis, Insights and Forecast - By Region
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. Asia Pacific
    • 5.3.4. Rest of the World

6. North America Women's Health Devices Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Application
    • 6.1.1. General Health & Wellness
    • 6.1.2. Cancers & Other Chronic Diseases
    • 6.1.3. Reproductive Health
    • 6.1.4. Pregnancy & Nursing Care
    • 6.1.5. Pelvic & Uterine Healthcare
    • 6.1.6. Others
  • 6.2. Market Analysis, Insights and Forecast- By End User
    • 6.2.1. Hospitals & Clinics
    • 6.2.2. Home Healthcare
    • 6.2.3. Others
  • 6.3. Market Analysis, Insights and Forecast - By Country
    • 6.3.1. U.S.
    • 6.3.2. Canada

7. Europe Women's Health Devices Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast- By Application
    • 7.1.1. General Health & Wellness
    • 7.1.2. Cancers & Other Chronic Diseases
    • 7.1.3. Reproductive Health
    • 7.1.4. Pregnancy & Nursing Care
    • 7.1.5. Pelvic & Uterine Healthcare
    • 7.1.6. Others
  • 7.2. Market Analysis, Insights and Forecast- By End User
    • 7.2.1. Hospitals & Clinics
    • 7.2.2. Home Healthcare
    • 7.2.3. Others
  • 7.3. Market Analysis, Insights and Forecast- By Country/ Sub-Region
    • 7.3.1. U.K.
    • 7.3.2. Germany
    • 7.3.3. France
    • 7.3.4. Spain
    • 7.3.5. Italy
    • 7.3.6. Rest of Europe

8. Asia Pacific Women's Health Devices Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast- By Application
    • 8.1.1. General Health & Wellness
    • 8.1.2. Cancers & Other Chronic Diseases
    • 8.1.3. Reproductive Health
    • 8.1.4. Pregnancy & Nursing Care
    • 8.1.5. Pelvic & Uterine Healthcare
    • 8.1.6. Others
  • 8.2. Market Analysis, Insights and Forecast- By End User
    • 8.2.1. Hospitals & Clinics
    • 8.2.2. Home Healthcare
    • 8.2.3. Others
  • 8.3. Market Analysis, Insights and Forecast- By Country/ Sub-Region
    • 8.3.1. Japan
    • 8.3.2. China
    • 8.3.3. India
    • 8.3.4. Australia
    • 8.3.5. Rest of Asia Pacific

9. Rest of World Women's Health Devices Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast- By Application
    • 9.1.1. General Health & Wellness
    • 9.1.2. Cancers & Other Chronic Diseases
    • 9.1.3. Reproductive Health
    • 9.1.4. Pregnancy & Nursing Care
    • 9.1.5. Pelvic & Uterine Healthcare
    • 9.1.6. Others
  • 9.2. Market Analysis, Insights and Forecast- By End User
    • 9.2.1. Hospitals & Clinics
    • 9.2.2. Home Healthcare
    • 9.2.3. Others

10. Competitive Analysis

  • 10.1. Global Market Share Analysis (2025)
  • 10.2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based On Availability))
    • 10.2.1. Coloplast A/S
      • 10.2.1.1. Overview,
      • 10.2.1.2. Products,
      • 10.2.1.3. SWOT Analysis,
      • 10.2.1.4. Recent Developments,
      • 10.2.1.5. Strategies,
      • 10.2.1.6. Financials (Based On Availability)
    • 10.2.2. Hologic, Inc.
      • 10.2.2.1. Overview,
      • 10.2.2.2. Products,
      • 10.2.2.3. SWOT Analysis,
      • 10.2.2.4. Recent Developments,
      • 10.2.2.5. Strategies,
      • 10.2.2.6. Financials (Based On Availability)
    • 10.2.3. Boston Scientific Corporation
      • 10.2.3.1. Overview,
      • 10.2.3.2. Products,
      • 10.2.3.3. SWOT Analysis,
      • 10.2.3.4. Recent Developments,
      • 10.2.3.5. Strategies,
      • 10.2.3.6. Financials (Based On Availability)
    • 10.2.4. ALLERGAN (AbbVie, Inc.)
      • 10.2.4.1. Overview,
      • 10.2.4.2. Products,
      • 10.2.4.3. SWOT Analysis,
      • 10.2.4.4. Recent Developments,
      • 10.2.4.5. Strategies,
      • 10.2.4.6. Financials (Based On Availability)
    • 10.2.5. BD (Becton, Dickinson and Company)
      • 10.2.5.1. Overview,
      • 10.2.5.2. Products,
      • 10.2.5.3. SWOT Analysis,
      • 10.2.5.4. Recent Developments,
      • 10.2.5.5. Strategies,
      • 10.2.5.6. Financials (Based On Availability)
    • 10.2.6. F. Hoffmann-La Roche Ltd
      • 10.2.6.1. Overview,
      • 10.2.6.2. Products,
      • 10.2.6.3. SWOT Analysis,
      • 10.2.6.4. Recent Developments,
      • 10.2.6.5. Strategies,
      • 10.2.6.6. Financials (Based On Availability)
    • 10.2.7. CooperSurgical Inc. (The Cooper Companies, Inc.)
      • 10.2.7.1. Overview,
      • 10.2.7.2. Products,
      • 10.2.7.3. SWOT Analysis,
      • 10.2.7.4. Recent Developments,
      • 10.2.7.5. Strategies,
      • 10.2.7.6. Financials (Based On Availability)
    • 10.2.8. Caldera Medical
      • 10.2.8.1. Overview,
      • 10.2.8.2. Products,
      • 10.2.8.3. SWOT Analysis,
      • 10.2.8.4. Recent Developments,
      • 10.2.8.5. Strategies,
      • 10.2.8.6. Financials (Based On Availability)
    • 10.2.9. Reckitt Benckiser Group PLC
      • 10.2.9.1. Overview,
      • 10.2.9.2. Products,
      • 10.2.9.3. SWOT Analysis,
      • 10.2.9.4. Recent Developments,
      • 10.2.9.5. Strategies,
      • 10.2.9.6. Financials (Based On Availability)

List of Tables

  • Table 01: Global Women's Health Devices Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 02: Global Women's Health Devices Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 03: Global Women's Health Devices Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 04: North America Women's Health Devices Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 05: North America Women's Health Devices Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 06: North America Women's Health Devices Market Revenue (USD billion) Forecast, by Country, 2021-2034
  • Table 07: Europe Women's Health Devices Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 08: Europe Women's Health Devices Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 09: Europe Women's Health Devices Market Revenue (USD billion) Forecast, by Country/Sub-Region, 2021-2034
  • Table 10: Asia Pacific Women's Health Devices Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 11: Asia Pacific Women's Health Devices Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 12: Asia Pacific Women's Health Devices Market Revenue (USD billion) Forecast, by Country/Sub-Region, 2021-2034
  • Table 13: Rest of World Women's Health Devices Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 14: Rest of World Women's Health Devices Market Revenue (USD billion) Forecast, by End User, 2021-2034

List of Figures

  • Figure 01: Global Women's Health Devices Market Value Share (%), by Application, 2025 & 2034
  • Figure 02: Global Women's Health Devices Market Value Share (%), by End User, 2025 & 2034
  • Figure 03: Global Women's Health Devices Market Value Share (%), by Region, 2025 & 2034
  • Figure 04: North America Women's Health Devices Market Value (USD billion), by Application, 2025 & 2034
  • Figure 05: North America Women's Health Devices Market Value Share (%), by Application, 2025
  • Figure 06: North America Women's Health Devices Market Value (USD billion), by End User, 2025 & 2034
  • Figure 07: North America Women's Health Devices Market Value Share (%), by End User, 2025
  • Figure 08: North America Women's Health Devices Market Value (USD billion), by Country, 2025 & 2034
  • Figure 09: North America Women's Health Devices Market Value Share (%), by Country, 2025
  • Figure 10: Europe Women's Health Devices Market Value (USD billion), by Application, 2025 & 2034
  • Figure 11: Europe Women's Health Devices Market Value Share (%), by Application, 2025
  • Figure 12: Europe Women's Health Devices Market Value (USD billion), by End User, 2025 & 2034
  • Figure 13: Europe Women's Health Devices Market Value Share (%), by End User, 2025
  • Figure 14: Europe Women's Health Devices Market Value (USD billion), by Country/Sub-Region, 2025 & 2034
  • Figure 15: Europe Women's Health Devices Market Value Share (%), by Country/Sub-Region, 2025
  • Figure 16: Asia Pacific Women's Health Devices Market Value (USD billion), by Application, 2025 & 2034
  • Figure 17: Asia Pacific Women's Health Devices Market Value Share (%), by Application, 2025
  • Figure 18: Asia Pacific Women's Health Devices Market Value (USD billion), by End User, 2025 & 2034
  • Figure 19: Asia Pacific Women's Health Devices Market Value Share (%), by End User, 2025
  • Figure 20: Asia Pacific Women's Health Devices Market Value (USD billion), by Country/Sub-Region, 2025 & 2034
  • Figure 21: Asia Pacific Women's Health Devices Market Value Share (%), by Country/Sub-Region, 2025
  • Figure 22: Rest of World Women's Health Devices Market Value (USD billion), by Application, 2025 & 2034
  • Figure 23: Rest of World Women's Health Devices Market Value Share (%), by Application, 2025
  • Figure 24: Rest of World Women's Health Devices Market Value (USD billion), by End User, 2025 & 2034
  • Figure 25: Rest of World Women's Health Devices Market Value Share (%), by End User, 2025
  • Figure 26: Global Women's Health Devices Market Share Analysis, By Company, 2025